Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

The Lancet

Volumn 345, Issue 8954, 1995, Pages 882-885

  den Heijer, M ^a   Gerrits, W B J ^a   Haak, H L ^a   Wijermans, P W ^a   Bos, G M J ^a   Blom, H J ^b   Rosendaal, F R ^c  

^a Department of Hematology Municipal Hospital Leyenburg ^*  (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHIONINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VEIN THROMBOSIS;

EID: 0028949953     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90008-X     Document Type: Article

References (20)

1. Plasma homocysteine and cardiovascular disease
2. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis
3. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
4. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
5. Homocysteine and other thiols in plasma and urine: automated determination and sample stability
6. Estimability and estimation of case-referent studies
7. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
8. Proportion of disease caused or prevented by a given exposure, trait or intervention
9. Plasma homocysteine assay in the exploration of thrombosis in young subjects
10. Plasma homocysteine in venous thromboembolism
11. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis
12. Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation
13. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
14. Homocysteine thiolactone N-homocysteine thiolactonyl retinamide and platelet aggregation
15. Will a decrease in blood homocysteine by vitamin supplementation reduce the risk for vascular disease?
16. Hyperhomocysteinemia and the response to vitamin supplementation
17. Treatment of mild hyperhomocysteinemia in vascular disease patients
18. Homocysteine and marginal vitamin deficiency-the importance of adequate vitamin intake